Status:
COMPLETED
Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy
Lead Sponsor:
Mayo Clinic
Conditions:
Nephrectomy
Laparoscopic Donor Nephrectomy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having laparoscopic surgery to donate a kidney.
Eligibility Criteria
Inclusion
- Patients donating a kidney via laparoscopic donor nephrectomy
Exclusion
- History of NSAID allergy
- Asthma
- History of long term opioid use
- Intraoperative blood loss greater than 300 mL
- Postoperative hemodynamic instability
- Active peptic ulcer disease
- Advanced renal impairment (Cr \> 2.0 mg/dL)
- Bleeding diathesis
- Current use of probenecid
- Pregnancy
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT00765232
Start Date
October 1 2008
End Date
November 1 2010
Last Update
January 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054